Coronavirus Disease 2019 (COVID-19)
FDA is working with U.S. government partners, including CDC, and international partners to address the pandemic.
Topic Paragraphs
Call-To-Action Title
FDA Commissioner Dr. Robert M. Califf and FDA's Center for Biologics Evaluation and Research Director Dr. Peter Marks will be taking questions
Call-To-Action Title
FDA Commissioner Dr. Robert M. Califf and FDA's Center for Biologics Evaluation and Research Director Dr. Peter Marks will be taking questions
Join us for a virtual press conference to discuss the FDA's draft recommendations to eliminate time-based deferrals for certain populations at increased risk of HIV and instead to assess blood donor eligibility using gender-inclusive, individual risk-based questions to reduce the risk of transfusion-transmitted HIV.
Virtual Press Conference: Blood Donation Guidance – 1/27/2023Featured Topics
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Jan 26
Joy Joy’s Bakery Issues Allergy Alert on Undeclared Wheat in Ube Spanish Bread, Ube Ensaymada, and Ube Roll
Food & Beverages
Jan 25
Snack Innovations Inc. Conducts Voluntary Recall on a Limited Quantity of Drizzilicious Mini Rice Cakes 4oz & .74oz and Popcorn 3.6oz Products in the U.S. Due to Undeclared Peanut Allergen on Packaging
Food & Beverages
Jan 25
Almondy is Initiating a Recall of a Limited Quantity of Almondy Chocolate Cake with Daim 14.1oz
Food & Beverages
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
FDA Approved Many New Drugs in 2022 That Will Improve the Lives of Patients and Consumers
In 2022, CDER approved 37 new drugs never before approved or marketed in the U.S., known as “novel” drugs.
Office of Digital Transformation’s New Focus on Technology Leadership
LMAP lays out our plans to strengthen our technology leadership capabilities to drive change at the business, technology, data, and cybersecurity levels.
FDA’s Cybersecurity Modernization Action Plan
CMAP will leverage Artificial Intelligence and Machine Learning technologies to enhance cyber detection and response capabilities.
Recently Published Guidances
Jan 30
CVM GFI #272 Practices to Prevent Unsafe Contamination of Animal Feed from Drug Carryover
Animal & Veterinary
Jan 27
Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products
Biologics
Jan 24
Draft Guidance for Industry: Action Levels for Lead in Food Intended for Babies and Young Children
Food & Beverages